These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38398311)

  • 21. Technology-Based Interventions for Substance Use and Comorbid Disorders: An Examination of the Emerging Literature.
    Sugarman DE; Campbell ANC; Iles BR; Greenfield SF
    Harv Rev Psychiatry; 2017; 25(3):123-134. PubMed ID: 28475504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parental Monitoring Predicts Depressive Symptom and Suicidal Ideation Outcomes in Adolescents Being Treated for Co-Occurring Substance Use and Psychiatric Disorders.
    MacPherson HA; Wolff J; Nestor B; Frazier E; Massing-Schaffer M; Graves H; Esposito-Smythers C; Spirito A
    J Affect Disord; 2021 Apr; 284():190-198. PubMed ID: 33607509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
    Beaulieu S; Saury S; Sareen J; Tremblay J; Schütz CG; McIntyre RS; Schaffer A;
    Ann Clin Psychiatry; 2012 Feb; 24(1):38-55. PubMed ID: 22303521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of patients comorbid for addiction and other psychiatric disorders.
    Brady KT; Verduin ML; Tolliver BK
    Curr Psychiatry Rep; 2007 Oct; 9(5):374-80. PubMed ID: 17915076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substance use and related disorders among persons exposed to the 9/11 terrorist attacks: Essentials for screening and intervention.
    Dowling FG; Lowe SM
    Arch Environ Occup Health; 2023; 78(5):261-266. PubMed ID: 36847147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.
    Compton MT; Weiss PS; West JC; Kaslow NJ
    Soc Psychiatry Psychiatr Epidemiol; 2005 Dec; 40(12):939-46. PubMed ID: 16247563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comorbidity of Personality Disorder among Substance Use Disorder Patients: A Narrative Review.
    Parmar A; Kaloiya G
    Indian J Psychol Med; 2018; 40(6):517-527. PubMed ID: 30533947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study.
    Curran GM; Sullivan G; Williams K; Han X; Allee E; Kotrla KJ
    BMC Emerg Med; 2008 Dec; 8():17. PubMed ID: 19055761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can Trans-Syndromal Prototypes ("Types") Improve Depiction of Complex Psychiatric Cases?: An Alternative Way to Consider Concordant Comorbid Psychiatric Disorders and Their Contexts as Coherent Units for Research, Assessment, and Treatment Planning.
    Yager J
    J Nerv Ment Dis; 2021 Jan; 209(1):1-8. PubMed ID: 33141784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 3-Year Course of Multiple Substance Use Disorders in the United States: A National Longitudinal Study.
    McCabe SE; West BT
    J Clin Psychiatry; 2017 May; 78(5):e537-e544. PubMed ID: 28406266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of substance abusing patients with comorbid psychiatric disorders.
    Kelly TM; Daley DC; Douaihy AB
    Addict Behav; 2012 Jan; 37(1):11-24. PubMed ID: 21981788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.
    Krawczyk N; Feder KA; Saloner B; Crum RM; Kealhofer M; Mojtabai R
    Drug Alcohol Depend; 2017 Jun; 175():157-163. PubMed ID: 28432939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substance Use Disorder.
    Swimmer KR; Sandelich S
    Emerg Med Clin North Am; 2024 Feb; 42(1):53-67. PubMed ID: 37977753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Adolescent Substance Use Disorders and Co-Occurring Internalizing Disorders: A Critical Review and Proposed Model.
    Hulvershorn LA; Quinn PD; Scott EL
    Curr Drug Abuse Rev; 2015; 8(1):41-9. PubMed ID: 25973718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychiatric and medical comorbidities of eating disorders: findings from a rapid review of the literature.
    Hambleton A; Pepin G; Le A; Maloney D; ; Touyz S; Maguire S
    J Eat Disord; 2022 Sep; 10(1):132. PubMed ID: 36064606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-reported psychotic disorders among Individuals with substance use disorders: findings from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Lev-Ran S; Imtiaz S; Le Foll B
    Am J Addict; 2012; 21(6):531-5. PubMed ID: 23082831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.
    McEvoy PM; Shand F
    J Anxiety Disord; 2008 Aug; 22(6):1087-98. PubMed ID: 18164585
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.